Note: Ingredients listed on restricted chemical lists
EC/CAS
63-42-3
Name of the chemical
Lactose C12H22O11
Concentration
N/A
EC/CAS
209-150-3
Name of the chemical
Aluminium, zinc, magnesium and calcium stearates
Concentration
N/A
EC/CAS
200-559-2
Name of the chemical
Lactose C12H22O11
Concentration
N/A
General Information
Revision date
2009-09-08
Product name
CARDURA ; SUPRESSIN; PROSTADILAT; ALFADIL
Emergency telephone
(24 hours) 1-800-424-9300
Icons in SDS
Company Information
company name
Pfizer Inc
e-mail address of the competent person responsible for the Safety Data Sheet
pfizer-MSDS@pfizer.com
GHS Information
Signal word
WARNING
Section 2
SECTION 2: Hazards identification
Appearance: Green tablets
Signal word
WARNING
Hazard statements
Harmful to aquatic life with long lasting effects.
Additional information
Short Term: Dust may cause irritation Individuals sensitive to this chemical or other materials in its chemical class may develop allergic reactions. Long Term: Repeat-dose studies in animals have shown a potential to cause adverse effects on heart. Known Clinical Effects: The most common adverse effects reported with the therapeutic use of doxazosin include hypotension (low blood pressure), dizziness, sleepiness, malaise, and fatigue. EU Risk Phrases: R52/53 - Harmful to aquatic organisms, may cause long-term adverse effects in the aquatic environment. Australian Hazard Classification
Hazardous Ingredients
Non-Dangerous Goods (NOHSC): Note: This document has been prepared in accordance with standards for workplace safety, which require the inclusion of all known hazards of the product or its ingredients regardless of the potential risk. The precautionary statements and warnings included may not apply in all cases. Your needs may vary depending upon the potential for exposure in your workplace.
